09.01.2024 |
"Neurophysiological correlates of alcohol-specific inhibition in alcohol use disorder and its association with craving and relapse" Hallie M Batschelet et al. Clinical Neurophysiology Volume 132, Issue 6, June 2021 |
Dendorfer Stefan |
16.01.2024 |
"Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression" G.M. Goodwin et al. N Engl. J. Med 2022;387:1637-48.DOI: 10.1056/NEJMoa2206443 |
Trobonjaca Marta |
23.01.2024 |
"Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder" Eline B. Rognli et al. N. Engl J Med 2022 Nov 3;387(18):1637-1648.doi: 10.1056/NEJMoa2206443 |
Hobi Sabine |
30.01.2024 |
"Community perinatal mental health teams and associations with perinatal mental health and obstetric and neonatal outcomes in pregnant women with a history of secondary mental health care in England: a national population-based cohort study" Ipek Gurol-Urganci et al. Lancet Psychiatry 2024 |
Brucker Stefanie |
06.02.2024 |
"Scaling-up problem management plus for refugees in Switzerland - a qualitative study" Julia Spaaij et al. BMC Health Services Research (2023)23:488 |
Wüest Laura |
13.02.2024 |
"Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind-semi-randomized trial" Erik Johnsen et al. Lancet Psychiatry 2020; 7:945-54 |
Verardo Paolo |
20.02.2024 |
"The dynamics of social activation and suspiciousness in individuals at ultra-high risk for psychosis" Laura A. Steenhuis et al. Schizophrenia Research 262 (2023) 67-75 |
Hütten Rahel |
27.02.2024 |
SKITAG ÄRZTESCHAFT - AUSFALL JC |
|
05.03.2024 |
"N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial" Jerome Sarris et al. Progress in Neuropsychopharmacology & Biological Psychiatry 117 (2022) 110550 |
Koopmann Moritz |
12.03.2024 |
"Potential for prediction of psychosis and bipolar disorder in Child and Adolescent Mental Health Services: a longitudinal register study of all people born in Finland in 1987" Ulla Lâng et al. World Psychiatry 21:3 October 2022 |
Jungen Samuel |
19.03.2024 |
"Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation - A Randomized Clinical Trial" Sebastian Walther, Danai Alexaki, Florian Weiss, Daniel Baumann, Alexandra Kyrou, Melanie Nuoffer, Forian Wüthrich et al.
JAMA Psychiatry. doi:10.1001/jamapsychiatry.2024.0026 |
Wüthrich Florian |
26.03.2024 |
"Personality profiles of factitious disorder imposed by mothers: A comparative analysis" Lauren B. Day et al. Journal of Child Custody, https://doi.org/10.1080/15379418.2017.1331780 |
Wagner Julia |
02.04.2024 |
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial Joanna Moncrieff et al. Lancet Psychiatry 2023: 10:848-59 |
Kunz Maribel |
09.04.2024 |
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study Alexander Denissoff et al Schizophrenia Bulletin https://doi.org/1093/schbul/sbae034 |
Malifatouratzis Alexios |
16.04.2024 |
Income inequalities beyond access to mental health care: a Dutch nationwide record-linkage cohort study of baseline disease severity, treatment intensity, and mental health outcomes Francisca Vargas Lopes et alLancet Psychiatry 2023;10:588-97 |
Reinke Roman |
23.04.2024 |
Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symtoms Arish Mudra Rakshasa-Loots et al. Translational Psychiatry (2023) 13:190;http://doi.org/10.1038/s41398-023-02489-0 |
Krasniak Eleonora |
30.04.2024 |
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizohrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial Inder Kaul et al. Lancet 2024;403:160-70 |
Birute Vaidelyte Ema |
07.05.2024 |
|
Dunker Suryan |
14.05.2024 |
|
Winkler Laura |
21.05.2024 |
|
Walz Yvonne |
28.05.2024 |
|
Abdolvand Anastasia |
04.06.2024 |
|
Schmid Olena |
11.06.2024 |
|
Stadler Erich |
18.06.2024 |
|
Skoliakova Katarina |
25.06.2024 |
|
Trojak Robert |
|
2. Semester |
|
13.08.2024 |
|
Grünig Pascal |
20.08.20245 |
|
Atomulesei Maria |
27.08.2024 |
|
Gurra Xhevit |
03.09.2024 |
|
Von Jürgensonn Silke |
10.09.2024 |
|
Roukens Yara |
17.09.2024 |
|
Frantz Manuel |
24.09.2024 |
|
Kühnis Claudio |
01.10.2024 |
|
Klima Isabell |
08.10.2024 |
|
Beck Jonas |
15.10.2024 |
|
Baloi Alina |
22.10.2024 |
|
Panagiota Ntinpoulou |
29.10.2024 |
|
Kobas Manuela |
05.11.2024 |
|
Sarikaya Ceren |
12.11.2024 |
|
Oniga Ioana Cristina |
19.11.2024 |
|
Schober Martin |
26.11.2024 |
|
Manser Julia |
03.12.2024 |
|
Trojak Robert |
10.12.2024 |
|
Ebralizde Archil |
17.12.2024 |
|
Nydegger Anna |
|
Feiertage, Start 1. Semester 2025 ab 07.01.2024 |
|
|
|
|